Report & Analysis Summary | Infectious Disease & Vaccines 

Summary of Long-term Trends in Enteric Virus Prevalence Among Young Children in South Africa (2009–2023)

Time to read: 04:52 
Time to listen: 08:52

 
Published on MedED: 29 October 2024 
Originally Published: 
 25 October 2024
Source: NCID
Type of article: Summary of  Report
MedED Catalogue Reference:  MNCS004

Category: Infectious Diseases, Vaccines & Antimicrobials
Cross-reference: Vaccines, Paediatrics & Neonatology

Keywords: enterovirus, rotavirus, adenovirus,vaccines, diarrhoeal disease, NCID
 

Originally Published in Public Health Bulletin, a National Institute for Communicable Diseases publication. This is a summary of the original report and in no way represents the original research. Links to all original material can be found at the end of this summary.
 

Key Take Aways

1. Enteric viruses, such as rotavirus, adenovirus, and norovirus, remain a major cause of diarrhoea and childhood mortality in South Africa

2. The rotavirus vaccine has significantly reduced rotavirus prevalence and related deaths, highlighting the need for continued vaccination efforts and enhanced public health interventions.

 


Top
Overview | Report Purpose | Methods | Findings | High-level Recommednations | Conclusion Original Research

 

Overview

 

 

A new report released by the National Institute for Communicable Diseases on Friday, 25th October, has highlighted the prevalence of enteric viruses in South Africa.

Globally, these viruses account for approximately 1.5 million deaths each year in children under five, underscoring their profound impact on child health. According to the report, enteric diseases in South Africa are a major cause of diarrhoea, leading to an estimated 15% of all childhood deaths in this age group. Notable viruses include rotavirus, adenovirus, and norovirus, which are easily transmissible through contaminated food, water, and close contact, resulting in widespread outbreaks, particularly in communities with inadequate access to clean water and sanitation.

 
Vulnerable populations—especially children under five years of age, older adults, and immunocompromised individuals—highlight the critical need for robust surveillance systems to monitor these infections, assess seasonal trends, and identify high-risk groups. 

Back to top

Report  Purpose

This report examines the long-term trends in enteric virus prevalence among children under five seeking treatment for diarrhoea at selected sentinel sites in South Africa between 2009 and 2023.

Back to top

Method

This 15-year surveillance study examined the prevalence of enteric viruses in children under five years old across various sentinel sites in South Africa, with a particular focus on the impact of the rotavirus (RV) vaccine introduced in 2009. 
 
The study encompassed three surveillance programmes: the Rotavirus Sentinel Surveillance Programme (RSSP, 2009–2020), ANDEMIA (2018–2022), and the Diarrhoeal Diseases Sentinel Surveillance (DDSS, 2020–2023), which covered multiple healthcare facilities across nine provinces.
 
Healthcare workers at a variable number of sentinel sites (ranging from 4 to 10 during the study period) collected stool samples from children under five who presented with acute diarrhoea at participating hospitals and clinics. 
 
The stool samples were analysed using reverse transcription polymerase chain reaction (RT-PCR) assays, which allow for the accurate identification of specific enteric viruses.
 
The case definition adhered to the World Health Organization's criteria for acute diarrhoea, defined as lasting seven days or fewer for the RSSP and up to 30 days for ANDEMIA.

 


Back to top
Findings 

Between 2009 and 2023, a total of 11,250 cases were enrolled, with 10,567 involving children under the age of five. Of these, 97% were registered at hospital sites.

General Occurrence
The enteric virus activity peaked between April and August, coinciding with South Africa’s cooler months. 

Virus Prevalence
Rotavirus was identified in 30% of stool samples collected, predominantly affecting children under five years old.

Adenovirus was found in 15% of cases, also primarily impacting younger children, while norovirus was detected in 10% of samples

Adenovirus prevalence increased significantly, rising from 20% in 2009 to 25% in 2022, with adenovirus type R accounting for 42% of the adenoviral strains.

Regarding other viral pathogens, norovirus GII accounted for an overall prevalence of 11%.


Vaccination Uptake and Impact
The impact of the RV vaccination campaign was evident, as no rotavirus was found in samples from children who died between 2018 and 2021, and only two deaths related to RV infection were recorded in 2022. 

The median age of infection for rotavirus cases was 8 months (interquartile range [IQR] 5–13 months), and the detection rate was higher in hospitals compared to clinics (26% vs. 20%). The baseline prevalence of rotavirus was 62% in 2009, while it currently stands at 22%. 
 
Vaccination rates peaked at 94% for one dose and 80% for two doses in 2019, with results indicating a protective effect for those receiving at least one dose against RV diarrhoea (adjusted odds ratio [aOR] 0.77 [95% confidence interval [CI] 0.69–0.85; p <0.001).
 
Clinical Outcomes
In terms of clinical outcomes, the study recorded a mortality rate of 2% over the study period (170 out of 9,085 cases). Of these, rotavirus accounted for 18% of the deaths (30 out of 170). 
 
COVID-19 Impact
The report also assessed the impact of COVID-19, finding that the prevalence of rotavirus dropped to 7% in 2020, while vaccination coverage declined to between 70% and 89% for a single dose (80–94% in 2019 vs. 70–89% in 2020 and 69–84% in 2021). 
 
These statistics underscore the heightened susceptibility of young children to enteric infections and highlight critical periods of increased viral activity. The data suggest a sustained pattern of enteric virus prevalence, emphasising the importance of ongoing monitoring and the need for targeted public health interventions.

 
Back to top  
 

High-level Recommendations

Based on the findings, the researchers made several recommendations including the following:

Ongoing monitoring and surveillance
It is imperative to continue and strengthen surveillance systems for enteric viruses, particularly in vulnerable populations such as children under five years old.  Ongoing monitoring will facilitate early detection of outbreaks and timely public health responses. 

Implement targeted vaccination programs.
Given the high prevalence of rotavirus and adenovirus in young children, targeted vaccination programmes should be promoted. To improve vaccination rates, the use of the paediatric rotavirus (RV) vaccine should be strongly encouraged among parents and healthcare workers. Administration is recommended at 6 and 14 weeks through the Expanded Programme on Immunisation (EPI) at both public and private clinics. 

Improved public health education
Education initiatives aimed at parents and caregivers should be implemented to increase awareness of the symptoms of enteric infections, the importance of hygiene, and safe food and water practices, particularly in communities at higher risk, alongside improvements in access to clean water and adequate sanitation facilities, especially in underserved areas. This will help reduce the transmission of enteric viruses and enhance overall community health.
 

Back to top
 


Conclusion

In conclusion, the findings from the report confirm that enteric viruses pose a significant health threat to young children in South Africa. Ongoing surveillance and targeted public health initiatives are essential to mitigate the impact of these infections, particularly in vulnerable populations. By implementing the recommended strategies, it may be possible to reduce the burden of enteric viruses and enhance child health outcomes across the country.

 



Back to top

Disclaimer
This article is in no way presented as an original work.  Every effort has been made to attribute quotes and content correctly. Where possible, all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 

Fact-checking Policy

The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here accurately reflects the original material. Should you find inaccuracies or out-of-date content or have any additional issues with our articles, please make use of the Contact Us form to notify us.

 

 

 

 

 

 

 

Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution